Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Affiliations

• ¹ Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
• ² Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
• ³ Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan.
• ⁴ Department of Gastroenterological Surgery, Hiroshima University Hospital, Hiroshima, Japan.